Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29,067,614
-
Number of holders
-
112
-
Total 13F shares, excl. options
-
16,287,424
-
Shares change
-
-128,789
-
Total reported value, excl. options
-
$850,358,590
-
Value change
-
-$12,114,445
-
Put/Call ratio
-
54%
-
Number of buys
-
55
-
Number of sells
-
-42
-
Price
-
$52.21
Significant Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q3 2021
142 filings reported holding KRYS - Krystal Biotech, Inc. - COMMON STOCK as of Q3 2021.
Krystal Biotech, Inc. - COMMON STOCK (KRYS) has 112 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16,287,424 shares
of 29,067,614 outstanding shares and own 56.03% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (1,982,432 shares), FMR LLC (1,902,405 shares), BlackRock Inc. (1,541,386 shares), LORD, ABBETT & CO. LLC (1,067,158 shares), VANGUARD GROUP INC (888,658 shares), CREDIT SUISSE AG/ (771,954 shares), FRAZIER MANAGEMENT LLC (771,250 shares), STATE STREET CORP (737,053 shares), PICTET ASSET MANAGEMENT SA (637,492 shares), and First Light Asset Management, LLC (633,481 shares).
This table shows the top 112 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.